Judge Orders Arthrex, Inc. to Halt Some Suture Anchor Sales

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A federal judge orders Arthrex to halt sales of some of its suture anchor products in a patent infringement lawsuit filed by Smith & Nephew. Smith & Nephew (FTSE:SN, NYSE:SNN) claimed a win today in its long-running patent infringement battle with rival Arthrex, after a federal judge in Oregon ordered Arthrex to stop selling some of its suture anchors in the U.S. as of Oct. 2. Judge Michael Mosman of the U.S. District Court for Oregon also ordered Arthrex to either remove all advertising material for the infringing devices from its website as of yesterday or "post a disclaimer on its website stating that any use of the infringing suture anchors ... must not occur in the United States until the expiration of the ‘557 patent pursuant to an injunction entered against Arthrex," according to court documents.

Help employers find you! Check out all the jobs and post your resume.

Back to news